{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:41:34Z","timestamp":1792651294443,"version":"4.5.0"},"reference-count":75,"publisher":"American Medical Association (AMA)","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2022,12,13]]},"abstract":"<jats:sec id=\"ab-jsc220005-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Clinicians, patients, and policy makers rely on published results from clinical trials to help make evidence-informed decisions. To critically evaluate and use trial results, readers require complete and transparent information regarding what was planned, done, and found. Specific and harmonized guidance as to what outcome-specific information should be reported in publications of clinical trials is needed to reduce deficient reporting practices that obscure issues with outcome selection, assessment, and analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-jsc220005-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To develop harmonized, evidence- and consensus-based standards for reporting outcomes in clinical trial reports through integration with the Consolidated Standards of Reporting Trials (CONSORT) 2010 statement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-jsc220005-6\">\n                    <jats:title>Evidence Review<\/jats:title>\n                    <jats:p>Using the Enhancing the Quality and Transparency of Health Research (EQUATOR) methodological framework, the CONSORT-Outcomes 2022 extension of the CONSORT 2010 statement was developed by (1) generation and evaluation of candidate outcome reporting items via consultation with experts and a scoping review of existing guidance for reporting trial outcomes (published within the 10 years prior to March 19, 2018) identified through expert solicitation, electronic database searches of MEDLINE and the Cochrane Methodology Register, gray literature searches, and reference list searches; (2) a 3-round international Delphi voting process (November 2018-February 2019) completed by 124 panelists from 22 countries to rate and identify additional items; and (3) an in-person consensus meeting (April 9-10, 2019) attended by 25 panelists to identify essential items for the reporting of outcomes in clinical trial reports.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-jsc220005-7\">\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>The scoping review and consultation with experts identified 128 recommendations relevant to reporting outcomes in trial reports, the majority (83%) of which were not included in the CONSORT 2010 statement. All recommendations were consolidated into 64 items for Delphi voting; after the Delphi survey process, 30 items met criteria for further evaluation at the consensus meeting and possible inclusion in the CONSORT-Outcomes 2022 extension. The discussions during and after the consensus meeting yielded 17 items that elaborate on the CONSORT 2010 statement checklist items and are related to completely defining and justifying the trial outcomes, including how and when they were assessed (CONSORT 2010 statement checklist item 6a), defining and justifying the target difference between treatment groups during sample size calculations (CONSORT 2010 statement checklist item 7a), describing the statistical methods used to compare groups for the primary and secondary outcomes (CONSORT 2010 statement checklist item 12a), and describing the prespecified analyses and any outcome analyses not prespecified (CONSORT 2010 statement checklist item 18).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-jsc220005-8\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>This CONSORT-Outcomes 2022 extension of the CONSORT 2010 statement provides 17 outcome-specific items that should be addressed in all published clinical trial reports and may help increase trial utility, replicability, and transparency and may minimize the risk of selective nonreporting of trial results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jama.2022.21022","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T11:05:24Z","timestamp":1670929524000},"page":"2252","source":"Crossref","is-referenced-by-count":684,"title":["Guidelines for Reporting Outcomes in Trial Reports"],"prefix":"10.1001","volume":"328","author":[{"given":"Nancy J.","family":"Butcher","sequence":"first","affiliation":[{"name":"Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Monsour","sequence":"additional","affiliation":[{"name":"Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma J.","family":"Mew","sequence":"additional","affiliation":[{"name":"Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada"},{"name":"Department of Chronic Disease Epidemiology, School of Public Health, Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Wen","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Women\u2019s College Research Institute, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Moher","sequence":"additional","affiliation":[{"name":"Centre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Mayo-Wilson","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline B.","family":"Terwee","sequence":"additional","affiliation":[{"name":"Amsterdam University Medical Centers, Vrije Universiteit, Department of Epidemiology and Data Science, Amsterdam, the Netherlands"},{"name":"Department of Methodology, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssandra","family":"Chee-A-Tow","sequence":"additional","affiliation":[{"name":"Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Baba","sequence":"additional","affiliation":[{"name":"Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Gavin","sequence":"additional","affiliation":[{"name":"public panel member, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy M.","family":"Grimshaw","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Canada"},{"name":"Children\u2019s Hospital Research Institute of Manitoba, Winnipeg, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Saeed","sequence":"additional","affiliation":[{"name":"Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[{"name":"Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Askie","sequence":"additional","affiliation":[{"name":"NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Smith","sequence":"additional","affiliation":[{"name":"patient panel member, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mufiza","family":"Farid-Kapadia","sequence":"additional","affiliation":[{"name":"Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula R.","family":"Williamson","sequence":"additional","affiliation":[{"name":"MRC-NIHR Trials Methodology Research Partnership, Department of Health Data Science, University of Liverpool, Liverpool, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Szatmari","sequence":"additional","affiliation":[{"name":"Cundill Centre for Child and Youth Depression, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, The Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Tugwell","sequence":"additional","affiliation":[{"name":"School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"Bruy\u00e8re Research Institute, Ottawa, Ontario, Canada"},{"name":"Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Golub","sequence":"additional","affiliation":[{"name":"Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneeta","family":"Monga","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, The Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Vohra","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and Psychiatry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Marlin","sequence":"additional","affiliation":[{"name":"Clinical Trials Ontario, Toronto, Canada"},{"name":"Department of Public Health Sciences, Queen\u2019s University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy J.","family":"Ungar","sequence":"additional","affiliation":[{"name":"Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada"},{"name":"Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Offringa","sequence":"additional","affiliation":[{"name":"Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada"},{"name":"Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Neonatology, The Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"jsc220005r2","doi-asserted-by":"publisher","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"key":"jsc220005r3","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"jsc220005r4","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1186\/s13063-020-04440-w","article-title":"Outcome reporting recommendations for clinical trial protocols and reports: a scoping review.","volume":"21","author":"Butcher","year":"2020","journal-title":"Trials"},{"key":"jsc220005r5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jclinepi.2016.09.003","article-title":"Primary Outcomes Reporting in Trials (PORTal): a systematic review of inadequate reporting in pediatric randomized controlled trials.","volume":"81","author":"Bhaloo","year":"2017","journal-title":"J Clin Epidemiol"},{"issue":"17","key":"jsc220005r6","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1001\/jama.2017.13001","article-title":"Association of trial registration with reporting of primary outcomes in protocols and publications.","volume":"318","author":"Chan","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"jsc220005r7","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13063-019-3173-2","article-title":"COMPare: a prospective cohort study correcting and monitoring 58 misreported trials in real time.","volume":"20","author":"Goldacre","year":"2019","journal-title":"Trials"},{"issue":"1","key":"jsc220005r8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12874-020-01019-6","article-title":"Primary outcome reporting in adolescent depression clinical trials needs standardization.","volume":"20","author":"Monsour","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"jsc220005r9","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jclinepi.2021.05.003","article-title":"High incidence of outcome switching observed in follow-up publications of randomized controlled trials: meta-research study.","volume":"137","author":"Kampman","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"jsc220005r10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jclinepi.2017.05.007","article-title":"Multiple outcomes and analyses in clinical trials create challenges for interpretation and research synthesis.","volume":"86","author":"Mayo-Wilson","year":"2017","journal-title":"J Clin Epidemiol"},{"issue":"9913","key":"jsc220005r11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0140-6736(13)62228-X","article-title":"Reducing waste from incomplete or unusable reports of biomedical research.","volume":"383","author":"Glasziou","year":"2014","journal-title":"Lancet"},{"issue":"4","key":"jsc220005r12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jaac.2019.08.468","article-title":"From research to practice: the importance of appropriate outcome selection, measurement, and reporting in pediatric mental health research.","volume":"59","author":"Monga","year":"2020","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"10","key":"jsc220005r13","doi-asserted-by":"publisher","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the CONSORT statement.","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Ann Intern Med"},{"issue":"8","key":"jsc220005r14","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1001\/jama.2013.879","article-title":"Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension.","volume":"309","author":"Calvert","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"jsc220005r15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13063-019-3248-0","article-title":"Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).","volume":"20","author":"Butcher","year":"2019","journal-title":"Trials"},{"issue":"2","key":"jsc220005r16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000217","article-title":"Guidance for developers of health research reporting guidelines.","volume":"7","author":"Moher","year":"2010","journal-title":"PLoS Med"},{"key":"jsc220005r17","article-title":"Guidelines for reporting outcomes in trial protocols: the SPIRIT-Outcomes 2022 extension.","author":"Butcher","journal-title":"JAMA"},{"issue":"2","key":"jsc220005r18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023001","article-title":"Guidance for reporting outcomes in clinical trials: scoping review protocol.","volume":"9","author":"Butcher","year":"2019","journal-title":"BMJ Open"},{"key":"jsc220005r19","doi-asserted-by":"publisher","first-page":"g1687","DOI":"10.1136\/bmj.g1687","article-title":"Better reporting of interventions: Template for Intervention Description and Replication (TIDieR) checklist and guide.","volume":"348","author":"Hoffmann","year":"2014","journal-title":"BMJ"},{"issue":"7","key":"jsc220005r21","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jclinepi.2006.10.020","article-title":"Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns.","volume":"60","author":"Ferreira-Gonz\u00e1lez","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"jsc220005r22","doi-asserted-by":"publisher","first-page":"c3920","DOI":"10.1136\/bmj.c3920","article-title":"Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review.","volume":"341","author":"Cordoba","year":"2010","journal-title":"BMJ"},{"issue":"28","key":"jsc220005r23","doi-asserted-by":"publisher","DOI":"10.3310\/hta18280","article-title":"Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review.","volume":"18","author":"Cook","year":"2014","journal-title":"Health Technol Assess"},{"issue":"10","key":"jsc220005r25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-007953","article-title":"Minimally important difference estimates and methods: a protocol.","volume":"5","author":"Johnston","year":"2015","journal-title":"BMJ Open"},{"issue":"2","key":"jsc220005r26","first-page":"434","article-title":"Definition of clinical differences.","volume":"33","author":"de Vet","year":"2006","journal-title":"J Rheumatol"},{"issue":"7","key":"jsc220005r27","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.jclinepi.2009.12.015","article-title":"The minimal detectable change should not replace the minimal important difference.","volume":"63","author":"de Vet","year":"2010","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"jsc220005r28","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1001\/jama.2017.21903","article-title":"Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: the SPIRIT-PRO Extension.","volume":"319","author":"Calvert","year":"2018","journal-title":"JAMA"},{"key":"jsc220005r29","doi-asserted-by":"publisher","first-page":"c723","DOI":"10.1136\/bmj.c723","article-title":"The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed.","volume":"340","author":"Hopewell","year":"2010","journal-title":"BMJ"},{"issue":"7","key":"jsc220005r30","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jclinepi.2010.02.006","article-title":"The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes.","volume":"63","author":"Mokkink","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"jsc220005r32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jclinepi.2021.06.002","article-title":"Key concepts in clinical epidemiology: responsiveness, the longitudinal aspect of validity.","volume":"140","author":"Mokkink","year":"2021","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"jsc220005r33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jclinepi.2011.06.018","article-title":"A critical review of methods used to determine the smallest worthwhile effect of interventions for low back pain.","volume":"65","author":"Ferreira","year":"2012","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"jsc220005r34","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s11136-018-1798-3","article-title":"COSMIN guideline for systematic reviews of patient-reported outcome measures.","volume":"27","author":"Prinsen","year":"2018","journal-title":"Qual Life Res"},{"key":"jsc220005r35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"issue":"3","key":"jsc220005r36","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: defining standard protocol items for clinical trials.","volume":"158","author":"Chan","year":"2013","journal-title":"Ann Intern Med"},{"issue":"60","key":"jsc220005r37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta23600","article-title":"Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA2 five-stage study, including a workshop.","volume":"23","author":"Cook","year":"2019","journal-title":"Health Technol Assess"},{"key":"jsc220005r38","doi-asserted-by":"publisher","first-page":"k3750","DOI":"10.1136\/bmj.k3750","article-title":"DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial.","volume":"363","author":"Cook","year":"2018","journal-title":"BMJ"},{"issue":"9","key":"jsc220005r39","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1056\/NEJMsa1012065","article-title":"The ClinicalTrials.gov results database\u2013update and key issues.","volume":"364","author":"Zarin","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"jsc220005r41","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1741-7015-8-18","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.","volume":"8","author":"Schulz","year":"2010","journal-title":"BMC Med"},{"issue":"1","key":"jsc220005r43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1258\/jhsrp.2011.011131","article-title":"Driving up the quality and relevance of research through the use of agreed core outcomes.","volume":"17","author":"Williamson","year":"2012","journal-title":"J Health Serv Res Policy"},{"issue":"5","key":"jsc220005r44","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.jclinepi.2012.10.010","article-title":"Many scenarios exist for selective inclusion and reporting of results in randomized trials and systematic reviews.","volume":"66","author":"Page","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"jsc220005r45","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jclinepi.2021.01.026","article-title":"Patient reported outcome measures in clinical trials should be initially analyzed as continuous outcomes for statistical significance and responder analyses should be reserved as secondary analyses.","volume":"134","author":"Collister","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"jsc220005r47","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jclinepi.2020.11.024","article-title":"Minimal important difference estimates for patient-reported outcomes: a systematic survey.","volume":"133","author":"Carrasco-Labra","year":"2021","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"jsc220005r48","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12955-020-01398-w","article-title":"Practical issues encountered while determining minimal clinically important difference in patient-reported outcomes.","volume":"18","author":"Woaye-Hune","year":"2020","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"jsc220005r49","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12955-020-01344-w","article-title":"How is the minimal clinically important difference established in health-related quality of life instruments? review of anchors and methods.","volume":"18","author":"Mouelhi","year":"2020","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"jsc220005r50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/ebmental-2020-300164","article-title":"Mind the methods of determining minimal important differences: three critical issues to consider.","volume":"24","author":"Devji","year":"2021","journal-title":"Evid Based Ment Health"},{"key":"jsc220005r52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jclinepi.2017.07.014","article-title":"Cherry-picking by trialists and meta-analysts can drive conclusions about intervention efficacy.","volume":"91","author":"Mayo-Wilson","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"jsc220005r55","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12916-015-0520-3","article-title":"Comparison of registered and published outcomes in randomized controlled trials: a systematic review.","volume":"13","author":"Jones","year":"2015","journal-title":"BMC Med"},{"issue":"4","key":"jsc220005r58","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1037\/a0038498","article-title":"The validity of the multi-informant approach to assessing child and adolescent mental health.","volume":"141","author":"De Los Reyes","year":"2015","journal-title":"Psychol Bull"},{"issue":"23","key":"jsc220005r59","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1093\/jnci\/djp386","article-title":"Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes.","volume":"101","author":"Basch","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"jsc220005r61","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/ije\/dyw320","article-title":"An introduction to multiplicity issues in clinical trials: the what, why, when and how.","volume":"46","author":"Li","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"23","key":"jsc220005r63","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1001\/jama.2017.18556","article-title":"Guidelines for the content of statistical analysis plans in clinical trials.","volume":"318","author":"Gamble","year":"2017","journal-title":"JAMA"},{"issue":"12","key":"jsc220005r64","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008431","article-title":"Reporting missing participant data in randomised trials: systematic survey of the methodological literature and a proposed guide.","volume":"5","author":"Akl","year":"2015","journal-title":"BMJ Open"},{"issue":"14","key":"jsc220005r65","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1056\/NEJMsr1203730","article-title":"The prevention and treatment of missing data in clinical trials.","volume":"367","author":"Little","year":"2012","journal-title":"N Engl J Med"},{"key":"jsc220005r67","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e2809","article-title":"Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review.","volume":"344","author":"Akl","year":"2012","journal-title":"BMJ"},{"issue":"7","key":"jsc220005r68","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s11136-015-1206-1","article-title":"The current practice of handling and reporting missing outcome data in eight widely used PROMs in RCT publications: a review of the current literature.","volume":"25","author":"Rombach","year":"2016","journal-title":"Qual Life Res"},{"issue":"404","key":"jsc220005r70","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1080\/01621459.1988.10478722","article-title":"A test of missing completely at random for multivariate data with missing values.","volume":"83","author":"Little","year":"1988","journal-title":"J Am Stat Assoc"},{"key":"jsc220005r71","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jclinepi.2020.07.015","article-title":"Public availability and adherence to prespecified statistical analysis approaches was low in published randomized trials.","volume":"128","author":"Kahan","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"jsc220005r74","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jclinepi.2021.10.023","article-title":"Harms in systematic reviews paper 1: an introduction to research on harms.","volume":"143","author":"Qureshi","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"jsc220005r75","doi-asserted-by":"publisher","first-page":"n1793","DOI":"10.1136\/bmj.n1793","article-title":"Do overly complex reporting guidelines remove the focus from good clinical trials?","volume":"374","author":"Howick","year":"2021","journal-title":"BMJ"},{"key":"jsc220005r31","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511996214","volume-title":"Measurement in Medicine","author":"de Vet","year":"2011"},{"key":"jsc220005r46","volume-title":"Design and Implementation of N-of-1 Trials: A User\u2019s Guide","author":"Kravitz","year":"2014"},{"key":"jsc220005r56","volume-title":"JBI Manual for Evidence Synthesis","author":"Campbell","year":"2020"},{"key":"jsc220005r69","volume-title":"The Prevention and Treatment of Missing Data in Clinical Trials","author":"National Research Council (US) Panel on Handling Missing Data in Clinical Trials","year":"2010"},{"key":"jsc220005r72","volume-title":"Guidelines for Reporting Health Research: A User\u2019s Manual","author":"Schriger","year":"2014"},{"key":"jsc220005r1","unstructured":"COSMIN. Consensus-based Standards for the selection of health Measurement Instruments (COSMIN) is an initiative of an international multidisciplinary team of researchers. Accessed April 13, 2021. https:\/\/www.cosmin.nl\/"},{"key":"jsc220005r20","unstructured":"CONSORT. CONSORT statement website. Accessed March 31, 2022. http:\/\/www.consort-statement.org\/"},{"key":"jsc220005r24","unstructured":"Mokkink? LB, Terwee? CB, Patrick? DL, . COSMIN checklist manual. Accessed February 28, 2022. https:\/\/fac.ksu.edu.sa\/sites\/default\/files\/cosmin_checklist_manual_v9.pdf"},{"key":"jsc220005r40","unstructured":"OMERACT. OMERACT (Outcome Measures in Rheumatology): domain resources. Accessed May 19, 2022. https:\/\/omeract.org\/domain-selection\/"},{"key":"jsc220005r42","unstructured":"International Conference on Harmonisation. E3: structure and content of clinical study reports: step 4. Accessed February 28, 2022. https:\/\/www.ich.org\/page\/efficacy-guidelines"},{"key":"jsc220005r51","unstructured":"International Conference on Harmonisation. E9: statistical principles for clinical trials: current step 4 version. Accessed November 14, 2022. https:\/\/database.ich.org\/sites\/default\/files\/E9_Guideline.pdf"},{"key":"jsc220005r53","unstructured":"Butcher? NJ, Mew? E, Monsour? A, . A scoping review of outcome-reporting recommendations for clinical trial protocols and reports. Accessed April 26, 2022. https:\/\/osf.io\/6f5x7\/"},{"key":"jsc220005r54","unstructured":"Eunethta (European Network for Health Technology Assessment). Guideline: endpoints used for relative effectiveness assessment of pharmaceuticals: composite endpoints. Accessed February 28, 2022. https:\/\/www.eunethta.eu\/wp-content\/uploads\/2018\/01\/Composite-endpoints.pdf"},{"key":"jsc220005r57","doi-asserted-by":"crossref","unstructured":"Mokkink? LB, Prinsen? CAC, Patrick? DL, . COSMIN methodology for systematic reviews of Patient-Reported Outcome Measures (PROMS): user manual: version 1.0. Published 2018. Accessed November 14, 2022. https:\/\/cosmin.nl\/wp-content\/uploads\/COSMIN-syst-review-for-PROMs-manual_version-1_feb-2018.pdf","DOI":"10.1007\/978-3-319-69909-7_2972-2"},{"key":"jsc220005r60","unstructured":"FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource. Accessed May 19, 2022. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK338448\/"},{"key":"jsc220005r62","unstructured":"European Medicines Agency. Guideline on multiplicity issues in clinical trials. Accessed February 8, 2022. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-guideline-multiplicity-issues-clinical-trials_en.pdf"},{"key":"jsc220005r66","unstructured":"Higgins? JPT, Thomas? J, Chandler? J, . Cochrane Handbook for Systematic Reviews of Interventions, version 6.3. Accessed November 14, 2022. http:\/\/www.training.cochrane.org\/handbook"},{"key":"jsc220005r73","unstructured":"REDCap Research. CONSORT-Outcomes feedback form. Accessed February 28, 2022. https:\/\/redcapexternal.research.sickkids.ca\/surveys\/?s=EL4LAR3HHR"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2799401\/jama_butcher_2022_sc_220005_1670262078.21329.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T17:21:59Z","timestamp":1701537719000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2799401"}},"subtitle":["The CONSORT-Outcomes 2022 Extension"],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":75,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2022,12,13]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2022.21022","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,13]]}}}